Up a level |
Journal Article
Brockelmann, Paul J. (2022). Unfolding the potential of anti-programmed cell death protein 1 blockade in Hodgkin lymphoma - combination and personalisation? Br. J. Haematol., 196 (1). S. 10 - 13. HOBOKEN: WILEY. ISSN 1365-2141
Brockelmann, Paul J. and Borchmann, Peter (2022). Navigating increasingly individualised Hodgkin lymphoma treatments to optimally balance risks and benefits. Br. J. Haematol., 197 (5). S. 515 - 518. HOBOKEN: WILEY. ISSN 1365-2141
Brockelmann, Paul J., Muller, Horst, Guhl, Teresa, Behringer, Karolin, Fuchs, Michael ORCID: 0000-0003-3289-3272, Moccia, Alden A., Rank, Andreas, Soekler, Martin, Vieler, Tom, Pabst, Thomas, Baues, Christian, von Tresckow, Bastian, Borchmann, Peter and Engert, Andreas (2021). Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. J. Clin. Oncol., 39 (2). S. 107 - 122. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755
Brockelmann, Paul J., de Jong, Mathilde R. W. and Jachimowicz, Ron D. (2020). Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma. Cells, 9 (10). BASEL: MDPI. ISSN 2073-4409
Brockelmann, Paul J., von Tresckow, Bastian and Engert, Andreas (2022). Novel therapeutic approaches in relapsed or refractory Hodgkin lymphoma. Onkologie, 28 (10). S. 901 - 908. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234
von Tresckow, Bastian, Kreissl, Stefanie, Goergen, Helen, Brockelmann, Paul J., Pabst, Thomas, Fridrik, Michael, Rummel, Mathias, Jung, Wolfram, Thiemer, Julia, Sasse, Stephanie, Burkle, Carolin, Baues, Christian, Diehl, Volker, Engert, Andreas and Borchmann, Peter (2018). Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials. Lancet Haematol., 5 (10). S. E462 - 12. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026